Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	43.27	14.01	9.78
Graham Fair Price	-35.84	3105.47	4840.43
PEG	-1270.22	-0.14	< 0.005
Price/Book	-1.47	0.69	0.70
Price/Cash Flow	inf	0.00	22.75
Prices/Earnings	152.26	8.09	3.21
Price/Sales	21.30	1.62	1.33
Price/FCF	inf	0.00	22.75
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	-2.57	0.41	0.42
Operating Margin	-38.25	0.09	0.15
ROA	-56.33	0.01	0.03
ROE	0.05	0.02	-60.94
ROIC	0.04	0.02	-48.95
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	-0.60	-0.04	-1505.76
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	3.12	-0.49	-84.38
EPS QOQ	3.25	-0.60	-81.59
FCF QOQ	< 0.005	0.00	inf
Revenue QOQ	0.89	-0.17	-80.95
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	52.59	52.44	-0.28
Days Sales Outstanding (DSO)	46.93	42.00	-10.52
Inventory Turnover	1.71	1.72	0.28
Debt/Capitalization	0.22	0.10	-55.00
Quick Ratio	0.72	0.83	15.74
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	4365.76	4481.80	2.66
Cash	314.31	191.81	-38.97
Capex	0.00	n.A.	n.A.
Free Cash Flow	134.53	n.A.	n.A.
Revenue	2296.59	1915.03	-16.61
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	1.13	1.36	20.51
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.31	1.28	-44.68
Naive Interpretation	Member

06 - Financial Health · Weak

Rating